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Inﬂammation in the vascular wall is important for the development of atherosclerosis. We have previ-
ously shown that inﬂammatory macrophages are more abundant in human atherosclerotic lesions than
in healthy arteries. Activated macrophages produce reactive oxygen species (ROS) that promote local
inﬂammation in atherosclerotic lesions. Here, we investigated the role of oregonin, a diarylheptanoid, on
proinﬂammatory responses in primary human macrophages and found that oregonin decreased cellular
lipid accumulation and proinﬂammatory cytokine secretion. We also found that oregonin decreased ROS
production in macrophages. Additionally, we observed that treatment of lipopolysaccharide-exposed
macrophages with oregonin signiﬁcantly induced the expression of antioxidant-related genes,
including Heme oxygenase-1 and NADPH dehydrogenase quinone 1. In summary, we have shown that
oregonin reduces lipid accumulation, inﬂammation and ROS production in primary human macrophages,
indicating that oregonin has anti-inﬂammatory bioactivities.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Macrophages that are derived from foam cells play integral roles
in atherosclerosis and are key regulators of lipid-driven
proinﬂammatory responses that promote atherosclerosis [1]. We
have previously shown that ischemia induces lipid accumulation in
primary human macrophages [2]. An inﬂammatory subset of
macrophages accumulates in atherosclerotic lesions and produces
proinﬂammatory cytokines, such as tumor necrosis factor (TNF)-a,
interferon (IFN)-g, interleukin (IL)-1b, and IL-6 [1,3]. Direct
evidence for the critical role of inﬂammation in regulating early
atherogenic events in atherosclerosis was provided by the ﬁnding
that sub-endothelial monocytes could develop into foam cells after
trans-endothelial migration across a TNF-a activated endotheliumepartment of Molecular and
ska Academy, University of
. Hulten).
Inc. This is an open access article u[4,5]. The numbers of proinﬂammatory macrophages have been
shown to be increased in symptomatic compared with
asymptomatic lesions [6]. Additionally, proinﬂammatory markers
are expressed at higher levels in macrophages from human carotid
lesions, suggesting a role for these cells in the atherosclerotic
process. High levels of reactive oxygen species (ROS) in the artery
wall are widely considered to promote atherosclerosis progression
and possibly even initiation [7]. ROS are highly reactive molecules
that are continuously produced by the mitochondrial electron
transport chain and by ROS producing enzymes, such as NADPH-
oxidases, xanthine oxidases, and lipoxygenases. At physiological
levels, ROS perform important regulatory functions within cells and
in tissues. At excessive levels, ROS irreversibly damage proteins,
lipids, carbohydrates, and DNA. ROS levels have been reported to be
high in stable atherosclerotic arteries, and such levels are even
higher in unstable lesions [8].
Oregonin, an open-chain diarylheptanoid glycoside containing
3-carbonyl and 5-xylosyloxy groups, is found in the Alnus plants.
Evidence indicates that this compound has anti-inﬂammatory and
anti-oxidant properties. For example, Alnus japonica bark has beennder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
A. Lundqvist et al. / Biochemical and Biophysical Research Communications 458 (2015) 693e699694used as a health food to enhance immunity against inﬂuenza [9].
Previous studies have shown that oregonin from A. japonica sup-
presses inﬂammation in rabbit macrophages by regulating NF-kB
signaling [10]. Furthermore, other studies have shown that orego-
nin reduces the expression of adhesionmolecules and IL-1b in TNF-
a-stimulated human endothelial cells [11]. Moreover, studies have
shown that Alnus acuminata bark extracts possess strong anti-
inﬂammatory bioactivities [12]. However, little is known about
the effects of oregonin from Alnus incana on lipid accumulation and
anti-inﬂammatory responses in primary human macrophages.
Here, we investigated the effect of oregonin from A. incana on
foam cell formation, inﬂammation, and ROS production in human
monocyte-derived macrophages and found that oregonin de-
creases cellular lipid accumulation, ROS production, and the
secretion of proinﬂammatory cytokines.2. Materials and methods
2.1. Oregonin isolation
Bark from the grey alder A. incanawas collected in southwestern
Latvia. Freeze-dried and powdered (ﬁne enough to pass through a
420-mm sieve) bark was sequentially extracted using a Soxhlet
apparatus with solvents of increasing polarity (ﬁrst hexane, then
ethyl acetate). The open-chain diarylheptanoid, 1,7-bis-(3,4-
dihydroxyphenyl)-heptan-3-one-5-O-b-D-xylopyronoside, known
as oregonin (Fig. 1A), was isolated from the bark ethyl acetate
extract to 95% purity using the Biotage (Charlottsville, VA, USA) SP1
preparative chromatography system with a reverse-phase column
(KPC18-HS, 35e70 mm, 90A, Biotage) using aqueous ethanol [13].Fig. 1. Decreased cytosolic lipid droplets in oregonin-treated primary human macro-
phages. A) Oregonin, the open-chain diarylheptanoid, 1,7-bis-(3,4-dihydroxyphenyl)-
heptan-3-one-5-O-b-D-xylopyronoside, was found to be the major bioactive com-
pound in bark extracts from the grey alder (Alnus incana). BeD) Primary human
macrophages were grown on chamber slides and incubated under ischemic conditions2.2. Primary human macrophages
Buffy coats were obtained from volunteer healthy adult blood
donors at Kung€alv Hospital, Sweden, and samples were made
anonymous before handling. Human mononuclear cells were iso-
lated by centrifugation over a discontinuous gradient of Ficoll-
Paque (GE Healthcare, Little Chalfont, UK). To obtain proin-
ﬂammatory macrophages, isolated cells were seeded in sterile 6-
well plates (TPP, Switzerland) at a cell density of 2  106 cells/mL
in RPMI medium and incubated for 2 h at 37 C in a 5% CO2 incu-
bator to allow adherence of monocytes. After washing off non-
adherent cells, monocytes were cultured in Macrophage-SFM me-
dia (Gibco, Carlsbad, CA, USA) containing granulocyte macrophage
colony stimulating factor (GM-CSF) to allow differentiation. After 3
days, the media was changed to RPMI media without GM-CSF and
cells were cultured for 4 days before use in experiments.(1% oxygen) for 24 h, in the absence or presence of 50 mmol/L oregonin. Lipid accu-
mulation was analyzed using Oil Red O staining. Representative images showing Oil
Red O staining of B) control and C) oregonin-treated macrophages. D) Quantiﬁcation of
the total area (mm2) of Oil Red O-stained lipid droplets per cell. Each bar indicates the
mean ± SEM of all cells present in 20 randomly selected micrographs from four
different donors. Bar 20 mm.2.3. Quantiﬁcation of Oil Red O-stained lipid droplets
Primary human macrophages were seeded in 8-well chamber
slides at a cell density of 400 000 cells/well (Lab-Tek Systems) as
described above. The cells were incubated under ischemic condi-
tions (1% oxygen) for 24 h, in the absence or presence of 50 mmol/L
oregonin. This oregonin concentration is shown to lower choles-
terol levels in rats with induced hypercholesterolemia [14]. Cells
were stained with Oil Red O and hematoxylin, and viewed with a
Zeiss Axioplan 2 microscope. We analysed20 randomly selected
images, containing approximately 20 cells/image, for each condi-
tion and blinded quantiﬁcation of the total area (mm2) of Oil Red
O-stained lipid droplets per cell was performed using BioPix iQ
2.2.1 (Gothenburg, Sweden; see www.biopix.se for further infor-
mation) [15].2.4. Cell viability
The cell viability was measured by using the Trypan blue
exclusion test. Cells incubated with LPS or with oregonin in 6-well
plate were cultured under normoxic conditions or hypoxic condi-
tions for 24 h. Then the cells were washed with PBS and 0.5 mL of
0.2% trypan blue solution in PBS was added onto the cells and
incubated for 5 min. Both the blue dead cells and living cells were
counted.
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Primary human macrophages seeded in sterile 6-well plates as
described above were incubated for 24 h, with or without 1 mg/mL
lipopolysaccharide from Salmonella enterica serotype typhimurium
(LPS; SigmaeAldrich, St. Louis, MO, USA), in the absence or pres-
ence of 50 mmol/L oregonin in RPMI 1640media. Secreted cytokines
(GM-CSF, IFN-g, IL-1b, IL-2, IL-6, IL-8, IL-10, IL-12p70, and TNF-a)
were measured in supernatants from these cells using the Human
Proinﬂammatory Multiplex assay (Meso Scale Discovery, Rockville,
MD, USA; K15007C) according to the manufacturer's instructions
and a SECTOR Imager 2400 reader (Meso Scale Discovery).2.6. ROS measurements
Primary human macrophages were incubated for 24 h with or
without 1 mg/mL LPS (Sigma), in the absence or presence of
50 mmol/L oregonin in RPMI 1640media. Hydrogenperoxide (H2O2)
levels were measured in lysates from 1  106 human macrophages
using the Amplex® Red Hydrogen Peroxide/Peroxidase Assay Kit
(Invitrogen, Paisley, UK).
Superoxide anion production was measured using isoluminol-
enhanced chemiluminescence (CL) [16]. The CL response was
detected in 5  105 human macrophages incubated in the absence
or presence of oregonin (50 mmol/L) in a total volume of 1.0 mL
Krebs Ringer Glucose Buffer containing 10 mg isoluminol (Sigma),
and 4 U horseradish peroxidase (Roche AB, Stockholm, Sweden).
Signals were quantiﬁed using a luminescence counter (Bio Orbit
Luminometer 1251, Turku, Finland). To activate the macrophages
and induce ROS production, 5 nmol/L phorbol myristate acetate
(PMA), a protein kinase C activator was added immediately prior to
the measurements. Chemiluminescence was recorded for 20 min.2.7. Quantitative PCR (q-PCR)
Primary human macrophages seeded in sterile 6-well plates as
described above were incubated for 24 h, with or without 1 mg/mL
lipopolysaccharide from S. enterica serotype typhimurium (LPS;
SigmaeAldrich, St. Louis, MO, USA), in the absence or presence of
50 mmol/L oregonin in RPMI 1640 media. RNA was isolated from
these cells using a RNeasy Mini Kit (Qiagen, Valencia, CA, USA) and
cDNA was synthesized using the RT2 First Strand Kit (C-03, Super-
Array, SABiosciences, Fredrick, MD, USA). Reverse transcription
reactions were performed with a Gene Amp PCR System 9700
(Applied Biosystems, Foster City, CA, USA). To assess the expression
of oxidative stress and antioxidant defense genes, the human PCR
Array (PAHS-065ZA, Qiagen) were used. Real-time PCR ampliﬁca-
tion was performed for 40 cycles using an ABI Prism 7900 HT
sequence detection system (Applied Biosystems). We analyzed q-
PCR data using the comparative CT method [17]. The relative
quantiﬁcation of target gene mRNA expression levels was
normalized to HPRT1 mRNA expression.2.8. Statistics
Values are mean ± SEM. All analyses were performed with
GraphPad Prism version 6.0 for Windows (GraphPad Software).
Student's t-test was used for comparison between two groups.
Values of P < 0.05 were considered signiﬁcant. The GeneGlobe Data
Analysis Center (Qiagen) was used to analyze real-time PCR data
based on the DDCt method with normalization of the raw data to
HPRT1 housekeeping gene as control and a criterion of fold change
1.5 to be considered as up- or down regulated.3. Results
3.1. Oregonin treatment decreases the accumulation of cytosolic
lipid droplets in human macrophages
To investigate the inﬂuence of oregonin on lipid droplet for-
mation, human macrophages were incubated in ischemic condi-
tions, which have previously been shown to increase cytosolic lipid
droplets, in the absence or presence of oregonin. Exposure of hu-
man macrophages to oregonin decreased the pool of cytosolic lipid
droplets, measured as the total area of Oil Red O-stained lipid
droplets per cell (Fig. 1BeD).
3.2. Oregonin reduces cytokine production in LPS-activated human
macrophages
We next tested the capacity of oregonin to reduce inﬂammation
in macrophages that were activated by LPS. Oregonin signiﬁcantly
reduced levels of the inﬂammatory cytokines TNF-a, IL-1b, IL-2, IL-
6, IL-10, and IL-12p70 in the supernatants of LPS-activated mac-
rophages, whereas no changes were found in macrophages that
were not treated with LPS (Fig. 2AeI). Analyses of GM-CSF, IFN-g,
and IL-8 levels showed no signiﬁcant change after oregonin treat-
ment (Fig. 2A, B and G). Exposure to 50 mmol/L oregonin did not
signiﬁcantly affect human macrophage viability, as measured by
the trypan blue exclusion test (Fig. 2J).
3.3. Oregonin reduces the production of ROS by human
macrophages
To study the effect of oregonin on ROS formation, we analyzed
H2O2 levels in lysates from human LPS-activatedmacrophages after
24 h incubation with or without oregonin. After incubation with
oregonin, H2O2 levels were signiﬁcantly decreased (Fig. 3A). Taken
together, these results suggest that oregonin reduces the produc-
tion of ROS in human proinﬂammatory macrophages. We also
investigated the role of oregonin on the production of superoxide
anion by PMA-activated macrophages. The addition of 50 mmol/L
oregonin to macrophages led to reduction of the CL signal (Fig. 3B).
3.4. Oregonin induces the expression of antioxidant-related genes
in LPS-exposed primary human macrophages
To elucidate the mechanisms involved in the antioxidant effects
of oregonin on macrophages, we compared the levels of oxidative
stress and antioxidant defense genes in LPS-exposed primary hu-
man macrophages (Table 1). The transcriptional proﬁling of the 84
oxidative stress related genes was obtained by the Human Oxida-
tive stress and Antioxidant defense RT2 Proﬁler PCR array and was
used to produce a hierarchical clustering scheme of 25 signiﬁcantly
regulated genes (Fig. 4). We found that oregonin increased the
mRNA expression levels of HMOX1 by 95-fold and HSPA1A by 35-
fold (Table 1). Oregonin also increased the mRNA expression
levels of several antioxidant-related genes (GPX4, GSS, GSTP1, SOD1,
SQSTM1, SRXN1, TXN, and TXNRD1) and reduced the mRNA
expression levels of several important oxidative stress responsive
genes (CCL5, MPO, NCF1, PDLIM1, PTGS1, PTGS2, and PREX1).
4. Discussion
In this study, we characterized the effects of oregonin, a natural
diarylheptanoid isolated from A. incana, on inﬂammatory re-
sponses in human macrophages. We found that oregonin caused
decreased macrophage lipid accumulation, decreased cytokine and
ROS production.
Fig. 2. Decreased cytokine production in oregonin-treated primary human macrophages. Primary human macrophages were incubated with or without 1 mg/mL LPS and 50 mmol/L
oregonin. Cytokine concentrations in supernatants were measured after 24 h. Quantiﬁcation of secreted cytokines in supernatants: A) TNF-a; B) IL-1b; C) IL-2; D) IL6; E) IL-10; F)
IL12p70; G) GM-CSF; H) IFN-g; and I) IL-8. J) Exposure to 50 mmol/L oregonin did not affect cell viability (measured by the trypan blue exclusion test). Each bar indicates the
mean ± SEM of primary human macrophage cultures (n ¼ 4 different donors).
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event in atherogenesis, and macrophage-derived foam cells pro-
motes lesion progression and themajority of acute complications of
atherosclerotic disease [7]. We found that oregonin caused mark-
edly decreased cellular lipid accumulation in ischemic human
macrophages, suggesting that oregonin reduces foam cell forma-
tion. These observations support previously reported ﬁndings
about treatment of hypercholesterolemic rats with oregonin leads
to reduction of blood lipids as well as reduced content of lipid
droplets in hepatocytes [14].The inﬂammatory response in leukocytes involves increased
production of lipid droplets, and that the enzymes involved in the
biosynthesis of eicosanoids, which are mediators of inﬂammation,
are localized around the lipid droplets [18]. Thus, the accumulation
of lipids in macrophages may be part of the inﬂammatory response
[19].
Further analyses of human macrophages revealed that oregonin
signiﬁcantly decreased the secretion of the proinﬂammatory cy-
tokines TNF-a, IL-1b, IL-2, IL-6, IL-10, and IL-12p70. Lipid-ﬁlled
macrophages in lesions generally have the properties of
Fig. 3. Oregonin decreases ROS production by primary human macrophages. A) Pri-
mary human macrophages were incubated for 24 h with or without 1 mg/mL LPS
(Sigma), in the absence or presence of 50 mmol/L oregonin. Oregonin decreases H2O2
production in human macrophages. Data are presented as fold changes in mean H2O2
levels ± SEM in primary human macrophages (n ¼ 4 different donors). B) Superoxide
anion production was measured after macrophage stimulation with 5 nmol/L PMA, in
the presence of 50 mmol/L oregonin or without oregonin (control). Chemiluminescence
was recorded for 20 min. ROS production by macrophages was expressed as maximal
peak values ± SEM (in mV) that were produced from 5  105 viable cells from four
macrophage donors.
Table 1
UpeDown Regulation of antioxidative and oxidative stress genes expressed in
lipopolysaccharide-exposed macrophages from three different macrophage donors
treated with oregonin and without as control.
Gene symbol Gene name Fold change P value
HMOX1 Heme oxygenase (decycling) 1 94.95 0.00006
HSPA1A Heat shock 70 kDa protein 1A 35.98 0.04650
GCLM Glutamate-cysteine ligase
modiﬁer subunit
16.46 0.00095
NQO1 NAD(P)H dehydrogenase quinone 1 7.30 0.00096
SOD1 Superoxide dismutase 1. soluble 5.88 0.00135
TXNRD1 Thioredoxin reductase 1 4.47 0.03491
SRXN1 Sulﬁredoxin 1 4.37 0.00041
BNIP3 BCL2/adenovirus E1B 19 kDa
interacting protein 3
3.58 0.00791
SQSTM1 Sequestosome 1 2.97 0.00114
GSTP1 Glutathione S-transferase pi 1 2.40 0.05178
CCS Copper chaperone for superoxide
dismutase
2.09 0.04436
GSS Glutathione synthetase 1.82 0.00355
GPX4 Glutathione peroxidase 4 1.70 0.06241
SIRT2 Sirtuin 2 1.67 0.04083
Downregulated genes
CCL5 Chemokine (CeC motif) ligand 5 20.44 0.06660
NCF1 Neutrophil cytosolic factor 1 15.61 0.00307
MPO Myeloperoxidase 14.26 0.02365
PDLIM1 PDZ and LIM domain 1 8.77 0.00937
PTGS1 Prostaglandin-endoperoxide
synthase 1
(prostaglandinG/H synthase
and cyclooxygenase)
7.75 0.00002
GPX1 Glutathione peroxidase 1 3.15 0.00466
CYBB Cytochrome b-245 beta polypeptide 2.46 0.02231
SOD2 Superoxide dismutase 2,
mitochondrial
2.28 0.02226
MSRA Methionine sulfoxide reductase A 2.01 0.03896
GTF2I General transcription factor IIi 1.74 0.03112
PDRX3 Peroxiredoxin 3 1.64 0.00278
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kines TNF-a and IFN-g. These cytokines cause the activation of
macrophages and vascular cells, promote inﬂammation, and
participate in cellular immunity [20]. Oregonin effectively reduced
myeloperoxidase (MPO) levels in macrophages. MPO is found in
atherosclerotic lesions [21], promotes foam cell formation [22], and
impairs cholesterol efﬂux frommacrophages [23]. Our data suggest
that the lipid-reducing effect of oregonin is partially mediated by
decreased MPO expression.
We also provide evidence for the importance of ROS in the anti-
inﬂammatory response observed in oregonin treated macrophages.
The role of ROS in inﬂammatory processes is unclear and ROS has
been described both as a trigger and effector of inﬂammation [24].
It has been reported that ROS may serve as important signaling
messengers and that superoxide anion and hydrogen peroxide are
ROS that may act as second messengers to activate inﬂammation
that results in IL-1b production [25]. Previous data showed that
extracts from A. japonica, including oregonin, had a superoxide
radical scavenging effect [26]. Several pathways have been sug-
gested to be involved in the antioxidant activity of oregonin in LPS-
activated rabbit macrophages, including the reduction of inducible
nitric oxide synthase (iNOS) and the induction of hemeoxygenase-1
[27]. We found no evidence of iNOS activation in oregonin-treated
human macrophages. These divergent results may relate to the use
of different cell types for oregonin treatment. In the presence of
oregonin, both superoxide anion and hydrogen peroxide produc-
tion is reduced in primary human macrophages, which suggests
that oregonin exhibits antioxidant activity that results in decreased
cytokine production.
The antioxidant effect of oregonin with reduced levels of ROS in
oregonin treated macrophages was consistent with observations
from our gene expression analysis. We found that the most stronglyinduced gene was Heme oxygenase decycling 1 (HMOX1) in
oregonin-treated macrophages. HMOX1 has antioxidant, anti-
inﬂammatory, and cytoprotective properties and is a rate-limiting
enzyme in heme catabolism [28]. Additionally, we observed
increased expression of Heat shock 70 kDa protein 1A (HSP701A) in
oregonin-treated cells. This ﬁnding might indicate the induction of
a defense mechanism against cytotoxic effects, as HSP90 has been
shown to protect cells from ischemic cell injury [29]. Our data
suggest that oregonin acts as an indirect antioxidant and exhibits
antioxidant effects by inducing cytoprotective compounds and
proteins, such as HMOX1, HSP70A1, glutamate-cysteine ligase
modiﬁer (GCLM), NAD(P)H quinone oxidoreductase 1(NQO1), sol-
uble superoxide dismutase (SOD1), and thioredoxin reductase
(TXNRD1) [30].
We also showed increased regulation of the genes for the
glutathione metabolic process in oregonin treated macrophages,
several genes in the glutathione pathway are induced by oregonin,
including GCLM, glutathione transferase (GSTP1), glutathione syn-
thase (GSS), and glutathione peroxidase (GPX 4). Glutathione has a
predominant role in the regulation of the intracellular redox state
and protects cells and tissues from oxidative injury [31].
Glutamate-cysteine ligase (GCL) is the ﬁrst rate-limiting enzyme in
glutathione synthesis. This enzyme consists of a catalytic subunit
and a modiﬁer subunit, GCLM. Low levels of GCLMmRNA in human
macrophages resulting from mutations in GCLM have been associ-
ated with susceptibility to myocardial infarction [32].
Under conditions of oxidative stress the chemokine CCL5 plays a
critical role as macrophage activator in atherosclerosis and
myocardial infarction [33]. We showed that the oxidative stress
responsive gene CCL5 is downregulated by oregonin. CCL5 are
increased by oxidative stress and are tightly connected to a
Fig. 4. Hierarchical clustering of oxidative stress and antioxidant defense genes. Each row represents a single gene; each column represents lipopolysaccharide-exposed macro-
phages from three different macrophage donors treated with oregonin and without (control).
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hibition of ROS prevented NF-kB activation [34]. Furthermore,
expression of NCF1 the 47 kDa cytosolic subunit of neutrophil
NADPH oxidase is decreased by oregonin. The respiratory burst
induced via activation of NCF1 is one of the major mechanisms of
ROS formation in macrophages and is activated to produce super-
oxide anion [7]. Our chemiluminescence data show a decreased
superoxide production in oregonin exposed macrophages which
may be explained by the reduced NCF1.
Our ﬁndings indicate that oregonin from A. incana decreases
inﬂammation, lipid accumulation, and ROS production in primary
human macrophages. Oxidative stress, derived from excessive and
persistent production of ROS and a possible decrease in antioxidant
defenses, leads to increased amounts of inﬂammatory mediators
upon inﬂammatory challenge. Mechanisms underlying the effects
of oregonin on inﬂammation may be via modulation of oxidative
stress as we detect increased expression of protective genes and
reduced expression of oxidative stress responsive genes. We pro-
pose that the anti-inﬂammatory bioactivity of oregonin is mediated
through the HMOX1-regulated antioxidant defense pathway and
that oregonin may be a useful candidate therapeutic molecule to
use to treat oxidative stress-related diseases.Author contributions
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